Sanofi Stock Euronext Paris
Stocks
SANNV
FR0014013QA3
Pharmaceuticals
OTC Markets Traded| Market Cap | 90.17B 104B 85.34B 77.53B 145B 9,914B 146B 1,016B 393B 5,039B 389B 380B 16,130B | P/E 2026 * |
12x | P/E 2027 * | 10.4x |
|---|---|---|---|---|---|
| Enterprise Value | 102B 117B 96.19B 87.39B 163B 11,175B 164B 1,146B 443B 5,679B 438B 429B 18,180B | EV / Sales 2026 * |
2.13x | EV / Sales 2027 * | 1.94x |
| Free-Float |
88.34% | Yield 2026 * |
5.65% | Yield 2027 * | 5.97% |
Last Transcript: Sanofi
| 1 day | +6.12% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 2026-04-30 | |
| Director of Finance/CFO | 64 | 2024-03-31 | |
Paulo Fontoura
CTO | Chief Tech/Sci/R&D Officer | - | 2026-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 61 | 2019-04-29 | |
Rachel Duan
BRD | Director/Board Member | 57 | 2020-04-27 |
Lise Kingo
BRD | Director/Board Member | 65 | 2020-04-27 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.12% | -1.27% | - | - | 104B | |
| +1.28% | +2.62% | +51.61% | +100.19% | 1,027B | |
| +1.10% | +1.45% | +52.49% | +67.37% | 651B | |
| +0.58% | +3.54% | +19.57% | +73.56% | 467B | |
| +0.80% | +5.87% | +39.35% | +41.27% | 350B | |
| +0.48% | +4.14% | +20.66% | +26.80% | 268B | |
| +1.08% | +7.19% | +11.58% | +16.98% | 257B | |
| +0.91% | -0.70% | +38.25% | +45.67% | 205B | |
| +1.55% | +2.68% | -27.68% | -56.36% | 190B | |
| +2.17% | +4.20% | +34.41% | +99.41% | 187B | |
| Average | +0.96% | +2.49% | +26.69% | +46.10% | 400.23B | |
| Weighted average by Cap. | +0.06% | +2.62% | +35.44% | +62.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 47.65B 54.71B 45.1B 40.97B 76.54B 5,239B 76.92B 537B 208B 2,663B 206B 201B 8,524B | 50.64B 58.14B 47.93B 43.55B 81.36B 5,569B 81.76B 571B 221B 2,830B 218B 214B 9,060B |
| Net income | 7.48B 8.59B 7.08B 6.43B 12.01B 822B 12.07B 84.31B 32.6B 418B 32.26B 31.54B 1,338B | 8.89B 10.2B 8.41B 7.64B 14.27B 977B 14.35B 100B 38.73B 497B 38.33B 37.47B 1,590B |
| Net Debt | 11.46B 13.16B 10.85B 9.86B 18.41B 1,260B 18.51B 129B 49.97B 641B 49.44B 48.34B 2,051B | 8.34B 9.57B 7.89B 7.17B 13.39B 917B 13.46B 93.97B 36.34B 466B 35.95B 35.15B 1,491B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
